Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | methionine aminopeptidase | 0.0234 | 0.5627 | 1 |
Leishmania major | methionine aminopeptidase, putative,metallo-peptidase, Clan MG, Family M24 | 0.0234 | 0.5627 | 0.5 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapA (map) (peptidase M) (MetAP) | 0.0148 | 0 | 0.5 |
Trypanosoma brucei | metallo- peptidase, Clan MG, Family M24 | 0.0234 | 0.5627 | 0.5 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPB (MAP) (PEPTIDASE M) | 0.0148 | 0 | 0.5 |
Brugia malayi | Methionine aminopeptidase protein type I | 0.0234 | 0.5627 | 0.5 |
Trypanosoma cruzi | metallo- peptidase, Clan MG, Family M24 | 0.0234 | 0.5627 | 0.5 |
Trypanosoma cruzi | metallo- peptidase, Clan MG, Family M24 | 0.0234 | 0.5627 | 0.5 |
Plasmodium vivax | methionine aminopeptidase 1b, putative | 0.0234 | 0.5627 | 1 |
Chlamydia trachomatis | methionine aminopeptidase | 0.0148 | 0 | 0.5 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0301 | 1 | 1 |
Treponema pallidum | methionine aminopeptidase (map) | 0.0148 | 0 | 0.5 |
Mycobacterium ulcerans | methionine aminopeptidase MapB | 0.0148 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | methionine aminopeptidase | 0.0148 | 0 | 0.5 |
Trypanosoma brucei | methionine aminopeptidase, putative | 0.0234 | 0.5627 | 0.5 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapB (map) (peptidase M) | 0.0148 | 0 | 0.5 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0301 | 1 | 1 |
Plasmodium falciparum | methionine aminopeptidase 1b, putative | 0.0234 | 0.5627 | 1 |
Echinococcus multilocularis | methionyl aminopeptidase 1 (M24 family) | 0.0234 | 0.5627 | 0.5627 |
Mycobacterium ulcerans | methionine aminopeptidase | 0.0148 | 0 | 0.5 |
Loa Loa (eye worm) | methionine aminopeptidase type I | 0.0234 | 0.5627 | 0.5 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPA (MAP) (PEPTIDASE M) (MetAP) | 0.0148 | 0 | 0.5 |
Trypanosoma brucei | methionine aminopeptidase, type I, putative | 0.0234 | 0.5627 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.